NEIL G SHAW
Veterinary in Tampa, FL
License number
Massachusetts 7380
Issued Date
Jul 19, 2013
Expiration Date
Feb 28, 2017
Type
Veterinarian
Address
Address
Tampa, FL 33614
Organization information
See more information about NEIL G SHAW at bizstanding.comNeil G Shaw DVM Acvim
3000 Busch Lk Blvd, Tampa, FL 33614
Industry:
Veterinary Services
Owner:
Neal Shaw (Owner)
Professional information
Medical Director At Florida Veterinary Specialists
Position:
Medical Director at Florida Veterinary Specialists
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Veterinary
Work:
Florida Veterinary Specialists
-
Medical Director
Education:
University of Florida 1986 - 1993
Catechin Adjuvants
US Patent:
2007008, Apr 12, 2007
Filed:
May 18, 2006
Appl. No.:
11/419101
Inventors:
Alberto van Olphen - Tampa FL, US
Herman Friedman - Tampa FL, US
Neil Shaw - Tampa FL, US
Nicholas Burdash - Tampa FL, US
James Roger - Tampa FL, US
Herman Friedman - Tampa FL, US
Neil Shaw - Tampa FL, US
Nicholas Burdash - Tampa FL, US
James Roger - Tampa FL, US
Assignee:
UNIVERSITY OF SOUTH FLORIDA - Tampa FL
International Classification:
A61K 36/82, A61K 31/7048, A61K 31/704, A61K 31/4745, A61K 31/66
US Classification:
424729000, 514034000, 514109000, 514027000, 514283000
Abstract:
A combination cancer therapy based upon catechins, the major biologically active polyphenol in plant products, including green tea extract, and one or more chemotherapeutic agents. A common complication of cancer chemotherapy is neutropenia, and in spite of advances in its prophylactic management is a major cause of risk for the development of serious microbial infections leading to increased morbidity and mortality in both humans and animals. The use of cathechins such as those found in green tea (), including but not limited to epigallocatechin gallate (EGCG) as nontoxic adjuvant to aid in the prevention of opportunistic microbial infections in patients undergoing immunosuppressive chemotherapy is a novel application. Also contemplated are methods using catechins to ameliorate the immunosuppressive effects of cancer chemotherapy by administering the compound to a patient in need thereof.